Countries
Industry
Startup stage
Startup size
Funding
Impact startup SDGs
Showing: 2314 filtered startups

UTVENDIG RENHOLD AS

Utvendig Renhold ble startet i 2010 med formål om å utføre vinduspuss for private og bedrifter. Etterhvert ble omfanget av tjenester mye større enn bare klassisk vinduspuss og omfatter nå alt utvendig renhold av bygninger for både private og næringsbygg .Selskapet har vært i konstant utvikling når det gjelder å ta i bruk nye metoder og ny teknologi. Dette har kommet kunder til gode, og gitt bedre kundeopplevelser. Vi holder i dag til i Kristiansand hvor vi har en etablert virksomhet. Vårt slogan er "Ingen strekker seg lenger" og betyr at vi leverer tjenester i verdensklasse. Dette klarer vi ved å levere riktig løsning, benytte riktig utstyr og ha en innovativ kompetanse på området til enhver tid.Vi ønsker å etablere Utvendig Renhold sitt konsept i de største byene i Norge. Dette skal vi gjøre gjennom etablering av franchiser i de ulike byene.

MyRent

MyRent is a cloud-based system for managing tenants and rent payment. Our customers are businesses renting out apartments in Norway. MyRent has been running since 2012, and with help from a customized CRM system, we started getting customers early on. Today handle about 28 Million NOK in monthly payments for our customers. Our goal is to get this platform out in Scandinavia, after building the bases in Norway.

Seald AS

Bile duct cancer is an aggressive form of cancer with an extremely poor overall five-year survival rate of just 2-5 %. Classified as an orphan disease, annual incidence in Europe and the United States of 15-22,000 patients, and a significantly higher incidence in Asia, makes it a major player and the deadliest of the gastrointestinal cancers. Only a small number of patients are eligible for a complete surgical resection by local resection or liver transplantation, and more than 50% of these relapse. The vast majority are treated by gemcitabine-based palliative chemotherapy with a life expectancy of 11 months, and five-year survival rate of zero %. Thus, there is an urgent and unmet medical need to develop new and better treatment strategies for these patients. The innovations developed by Seald are a result of adopting a multidisciplinary approach to the diagnosis and treatment of bile duct cancer, based on extensive drug sensitivity assays on living cancer cells, molecular biomarkers, DNA sequencing, extensive bioinformatics analyses and zebrafish models. Sealds’s holistic approach is unique with possible modes of action that can be used on other solid cancers. Our technology includes drug repurposing and innovation on new medical substances, diagnostics and methodology. The stipulated pharma market globally is USD 2.1-4.2 billion, in addition to the markets for diagnostics and platform technology

Pharmasum Therapeutics AS

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

Dynamisk Helse AS

The founder of Dynamisk Helse, Ann-Kristin Johansen, worked for several years as a nurse in hospitals and elderly care organizations. She experienced first-hand the lack of proper training which sometimes led to negative incidences for the patients as well as the staff. Sometimes the result had devastating outcomes, with a person's life at risk. Ann-Kristin felt sad and angry and felt the need to personally take action. This resulted in the foundation of Dynamisk Helse AS in 2011. We believe in small drops of theoretical and practical case-specific training, tailored naturally into our daily work. As there was no software platform available we felt was appropriate, we made it ourselves. Starting with making the “Drops first aid” app, which received fantastic feedback around the globe. (still available in Appstore) After this first test of response, we continued developing our own philosophy into a software platform that exceeds normal standards today. With limitless scalability and access on all digital surfaces. The number of elderly and inhabitants with chronic diseases, is going to double within ten years, resulting in dramatic demand for qualified healthcare workers. The leaders in healthcare struggle with high turnover and a shortage of both time and recourses to train the temps. Drops smartphone solution gives access to short and precise information about what to do when they need it, by scanning a QR code. Our Drops Skill aid system enables healthcare leaders to support staff in day-to-day tasks. We save costs for our customers, and provide a better service for patients, while we support care workers in building their skills and confidence.

LangO

LangO is changing the way companies deliver English language training to their employees online. We do this through a blended learning solution; a combination of live virtual lessons (Group Live Lessons and One-to-One) complemented by our on-demand micro-learning activities. Our responsive web app brings in the best-qualified teachers from around the world, custom-made LangO lesson content based on client's needs, and a scalable tech stack enabling employees to learn effectively on any device, at any time.

Norwegian White

"Transparently Norwegian"​ We carefully select guaranteed Norwegian products, ship them via our own "digital highway of trust"​ to ourselves (in China) and sell them directly to end-users in the world (starting with China) through our own e-Commerce platform (and soon in our own retail stores). We are in business, we control the whole value chain, we do it differently and our concept can't be copied by big American tech or food companies. We also represent business opportunities for other companies.

Optimeering Aqua AS

BioPlan optimizes production planning for all steps in the aquaculture value chain, from roe to harvest.BioPlan's algorithms represent the state-of-the-art in production optimization. They are the result of many years of in-depth research and development, both in-house and at the Norwegian University of Science and Technology in Trondheim, Norway. BioPlan is today used for planning salmon production with an annual sales value of 4 billion NOKOfficial launched of software in August 2017. Now building a customer base

Lima Regnskap AS

Lima Regnskap AS er et autorisert regnskapsførerselskap som utfører alt innen regnskap, lønn, konsulentbistand, årsavslutning og har erfaring innen de fleste bransjer. Videre bistår vi gjerne med oppstart og registrering av nye virksomheter. Regnskapsfirmaet startet opp 1 juli 2017. Kontoret har en sentral beliggenhet på Ålgård.

SoftOx Solutions AS

Antibiotic resistance and bacterial infections are a large threat to modern healthcare. The Norwegian company SoftOx Solutions has developed a patented technology with the potential of becoming a game changer in fighting infections. To achieve this SoftOx has a highly competent organization and established a long-term relationship with leading scientists from the University of Copenhagen and Excite International, Canada. SoftOx wound cleansing solution shall become the first antiseptic with solid clinical evidence of infection removal in chronic wounds, giving us a unique market position in a 90 billion NOK wound care market.

Ably Medical

Together with four Norwegian hospitals, we have developed the next generation hospital bed. A bed that prevents pressure ulcers, fall and reduce nurse load by removing heavy lifting and monitors the patients state, non intrusive. Have recieved contracts in Toronto that accelerates development, and secures uptake and sales if the clinical trial goes as planned.

AYR AS

AYR AS er bygget opp av to avdelinger, henholdsvis Kommunikasjon og Infrastruktur.Kommunikasjon leverer ytelsesbaserte kommunikasjonstjenester og markedsføring. Vi har derfor et stort fokus på det digitale. I Infrastrukturavdelingen leverer vi de tradisjonelle IT-tjenestene men den grunnleggende idéen er at vi skal bruke den nye teknologien, herunder skyteknologi. Vi ønsker å gjøre IT enkelt og kombinert med at tjenestene vi leverer er tett knyttet til hverandre – gir det kundene ett kontaktpunkt. Teknologi kan både påvirke samfunnet og miljøet. Alle som jobber i AYR ønsker at teknologisk utvikling skal dytte samfunnet i riktig retning, hvor teknologi gjør at alle kan bidra og bli hørt. Vi bidrar derfor gjennom at 5% av konsernets overskudd fordeles mellom barne- og ungdomsarbeid innenfor teknologi og støttearbeid innen teknologi i utviklingsland.

Scope321 AS

For SMB, who wants to create a carbon inventory and budget, the Scope321 platform is a carbon reporting tool, that is easy to use, automates data gathering and integrates with suppliers. Unlike current carbon reporting systems, our product will translate your accounting data into carbon data, so you don't have to track it in other systems or logs.

Airmine AS

Airmine is a technology company delivering pollen forecasts. Our vision is to help people who are affected by pollen allergies. New ways to deliver pollen forecasts - data-driven and local pollen forecasts, based on weather, topography, vegetation and measurements. We deliver local pollen forecasts as socially useful service.

Salire AS

Salire AS is a Norwegian tech-startup that develops applications that help small and medium sizes businesses grow. Our product AIFlow is an innovative CRM solution tailored around hundreds of Norwegian businesses. We like to call it a boosted CRM because it offers an all in one experience with a simple interface, eliminating the need for many applications to run your business daily.